Stephen Duguay
Vice President Head of Analytical Development at Ring Therapeutics
Based in Cambridge, United States
7-day free trial · no credit card
Seniority
Vp
Department
Science
Location
Cambridge
Industry
Biotechnology Research
Company size
51
Contact information
Reveal Stephen's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
s•••••••@ringtx.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Stephen Duguay
Scientist with extensive experience in the cell and gene therapy industry. Supported commercial manufacturing of two of the first FDA-approved cell therapies: Carticel and Epicel. Led process and assay development for MACI cell therapy (approved in US and Europe). Process and/or analytical development for three FDA/EMA approved autologous cell-based gene therapies: Zynteglo, Abecma, Skysona. Specialties: Gene Therapy, Cell Therapy, Regenerative Medicine, Analytical Development, Process Development; CMC Strategy, Functional and Cross-Functional Leadership.
Decision-makers
Other people at Ring Therapeutics
Build a list of verified contacts at Ring Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Stephen
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime